Health & Biotech
ASX Health Stocks: Acrux jumps 70pc after launching its acne gel in the US
Health & Biotech
Anteris Technologies is leading a heart condition treatment revolution
Health & Biotech
Medtech Optiscan beefs up operations in US, hires two high-level execs
Health & Biotech
ASX Health Stocks: NSB jumps 30pc after disclosing upcoming meeting with US FDA
Health & Biotech
Melodiol’s Mernova gains more traction in Canada: revenues increase, new products launched
Health & Biotech
MGC Pharmaceuticals rebrands as Argent BioPharma in strategic transformation
Health & Biotech
ASX Health Stocks: Argenica jumps 20pc on Phase 2 update, Fisher&Paykel could lose $12m from recall
Health & Biotech
Aroa Biosurgery targets sales growth and operations cash flow positivity in FY25
Health & Biotech
Melodiol subsidiaries contribute $3.1 million revenue in first two months of 2024
Health & Biotech
Race Oncology achieves ‘major milestone’ in progress of lead drug to human trials
Health & Biotech
Up and away – EZZ partners with Asia Pacific Aviator Club
Health & Biotech
The Calmer Co rides wave of rising kava demand as younger generations ditch alcohol
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.